Physician profile
Daniel E Nelson
NPI 1205878469
$29,314.40
in general payments reported to CMS, 2019-2025
31 companies · $3,516 in 2025
The $3,516 reported for 2025 was more than what 87% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,944 · 2020: $7,245 · 2021: $2,603 · 2022: $2,230 · 2023: $1,748 · 2024: $3,028 · 2025: $3,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,747 · Travel and Lodging: $2,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,747.49 |
| Travel and Lodging | $2,545.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14,561.35 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Si-Bone, INC. | $5,704.01 | 2019-2025 | |
| Nalu Medical, INC. | $1,808.95 | 2022-2024 | Nalu Neurostimulation System |
| Mml US, INC. | $1,621.48 | 2021-2025 | Reactiv8 |
| Vertiflex, INC. | $1,424.74 | 2019 | |
| Relievant Medsystems, INC. | $911.84 | 2022-2023 | Intracept |
| Nevro Corp. | $827.36 | 2019-2024 | Senza |
| Biotronik Nro, INC. | $451.67 | 2023-2025 | Biotronik, Prospera |
| Biotronik INC. | $448.24 | 2025 | |
| Painteq LLC | $264.05 | 2024 | Painteq |
| Vertos Medical, INC. | $252.77 | 2021-2024 | Mild Device Kit |
| Zyla Life Sciences, INC. | $177.49 | 2019-2020 | |
| Medtronic, INC. | $129.67 | 2024-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Foundation Fusion Solutions, LLC | $110.27 | 2022 | |
| Abbott Laboratories | $84.37 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $68.23 | 2020 | |
| Assertio Therapeutics, INC. | $67.03 | 2019 | |
| Medtronic USA, INC. | $65.34 | 2019-2020 | |
| Bioventus LLC | $51.53 | 2019-2020 | |
| Stimwave Technologies Incorporated | $40.46 | 2019-2020 | |
| Saluda Medical Americas, INC. | $30.24 | 2024-2025 | Evoke |
| Fidia Pharma USA INC. | $27.72 | 2025 | Hymhyn |
| Horizon Therapeutics Plc | $26.80 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $25.12 | 2025 | |
| Curonix LLC | $24.65 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Daiichi Sankyo INC. | $24.13 | 2019 | |
| Stratus Medical, LLC | $21.28 | 2023 | Nimbus |
| Scilex Pharmaceuticals INC. | $19.98 | 2019 | |
| Sentynl Therapeutics, INC. | $14.99 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $14.33 | 2019 | |
| Invictus Surgical Incorporated | $14.31 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.